Bioharvest Sciences (BHST) Net Margin (2023 - 2026)
Bioharvest Sciences (BHST) recorded Net Margin of -42.04% in the quarter ended Jun 30, 2026, up 5.88 percentage points from -47.92% a year earlier but down 10.99 percentage points from the prior quarter.
Bioharvest Sciences (BHST) Net Margin (2023 - 2026) Analysis & Trends
On a TTM basis, Bioharvest Sciences' Net Margin came in at -31.21% as of Jun 30, 2026, up 8.74 percentage points year-over-year; for the year ended Dec 31, 2025, it was -32.27%, up 19.00 percentage points from the prior year.
- Across earlier years, Net Margin came in at -51.27% in the year ended Dec 31, 2024 (+47.88 pp) and -99.15% in the year ended Dec 31, 2023.
- Quarterly Net Margin has ranged from -395.86% in the quarter ended Dec 31, 2023 to 103.64% in the quarter ended Jun 30, 2023 over the past five years.
- On a year-over-year basis, Net Margin rose in five of the last eight quarters, with an average year-over-year change of +44.00 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 355.25 percentage points in the quarter ended Dec 31, 2024, against a drop of 115.04 percentage points in the quarter ended Jun 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -31.05% (quarter ended Mar 31, 2026), -24.31% (quarter ended Dec 31, 2025) and -27.72% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Bioharvest Sciences | 27.06 Mn | -43.32 Mn | 5.08 Mn | -42.04% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.04% |
| Mar 31, 2026 | -31.05% |
| Dec 31, 2025 | -24.31% |
| Sep 30, 2025 | -27.72% |
| Jun 30, 2025 | -47.92% |
| Mar 31, 2025 | -29.75% |
| Dec 31, 2024 | -40.62% |
| Sep 30, 2024 | -41.12% |
| Jun 30, 2024 | -11.40% |
| Mar 31, 2024 | -123.15% |
| Dec 31, 2023 | -395.86% |
| Sep 30, 2023 | 53.32% |
| Jun 30, 2023 | 103.64% |
Bioharvest Sciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();